These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30668830)

  • 1. Cognitive/Functional Measures Predict Alzheimer's Disease, Dependent on Hippocampal Volume.
    Tabatabaei-Jafari H; Shaw ME; Walsh E; Cherbuin N
    J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1393-1402. PubMed ID: 30668830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple and clinically relevant combination of neuroimaging and functional indexes for the identification of those at highest risk of Alzheimer's disease.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Neurobiol Aging; 2018 Sep; 69():102-110. PubMed ID: 29864716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between hippocampal subfield volumes in mild cognitive impairment and conversion to Alzheimer's disease.
    Izzo J; Andreassen OA; Westlye LT; van der Meer D
    Brain Res; 2020 Feb; 1728():146591. PubMed ID: 31816319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease.
    Pearson MJ; Wagstaff R; Williams RJ;
    Brain Behav; 2024 Jul; 14(7):e3611. PubMed ID: 38956818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields.
    Kim GW; Kim BC; Park KS; Jeong GW
    Sci Rep; 2020 Jul; 10(1):10912. PubMed ID: 32616841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
    J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating individual trajectories of structural and cognitive decline in mild cognitive impairment for early prediction of progression to dementia of the Alzheimer's type.
    Rajagopal SK; Beltz AM; Hampstead BM; Polk TA
    Sci Rep; 2024 Jun; 14(1):12906. PubMed ID: 38839800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging texture predicts progression to dementia due to Alzheimer disease earlier than hippocampal volume.
    Lee S; Lee H; Kim KW;
    J Psychiatry Neurosci; 2020 Jan; 45(1):7-14. PubMed ID: 31228173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease.
    Barnes DE; Cenzer IS; Yaffe K; Ritchie CS; Lee SJ;
    Alzheimers Dement; 2014 Nov; 10(6):646-55. PubMed ID: 24495339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pineal volume reduction in patients with mild cognitive impairment who converted to Alzheimer's disease.
    Matsuoka T; Oya N; Yokota H; Akazawa K; Yamada K; Narumoto J;
    Psychiatry Clin Neurosci; 2020 Nov; 74(11):587-593. PubMed ID: 32609399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal [
    Wolters EE; Ossenkoppele R; Golla SS; Verfaillie SC; Timmers T; Visser D; Tuncel H; Coomans EM; Windhorst AD; Scheltens P; van der Flier WM; Boellaard R; van Berckel BN
    Neuroimage Clin; 2020; 25():102113. PubMed ID: 31835238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.